This article was updated on January 5, 2023.
Independence Blue Cross (Independence) and Independence Administrators will make changes to their Select Drug Program® Formulary and Value Formulary. The changes are effective January 1, 2023, and will include:
Changes in traditional glucose monitoring supplies
- Effective January 1, 2023, OneTouch® products will no longer be the preferred brand test strip/meters on the Select Drug Program and on the Value Formulary.
- On the Select Drug Program, OneTouch® and all non-Contour® test strips will be non-preferred and will require prior authorization.
- On the Value Formulary, OneTouch® and all non-Contour® test strips will be non-formulary.
- Contour® NEXT will be the preferred brand test strip/meters and will not require prior authorization.
- With the changes in preferred test strips, Independence is offering a free Contour® Next One meter. The new meter can be used with the preferred brand
Contour® test strips.
Changes in continuous glucose monitoring (CGM) supplies
- Effective January 1, 2023, Freestyle Libre® products will no longer be the preferred CGM on the Select Drug Program and on the Value Formulary.
- On the Select Drug Program, Freestyle Libre® will be non-preferred and will require prior authorization.
- On the Value Formulary, Freestyle Libre® will be non-formulary.
- Dexcom® products will be the preferred CGM. Prior authorization continues to be required for Dexcom.
Review the changes that go into effect January 1, 2023:
For more information on pharmacy policies and programs, visit the
Independence Blue Cross and
Independence Administrators websites.